Navigation Links
Sigma-Aldrich(R) Receives Award From Michael J. Fox Foundation to Develop Parkinson's Disease Research Models
Date:10/1/2009

reate rat models with particular genes deactivated, or 'knocked out.' However, using CompoZr ZFN technology, scientists at SAGE Labs are able to generate animal models with targeted genetic changes to better understand gene function and develop new therapeutic approaches.

For more information on this research program, visit http://www.sigma.com/sagelabs.

About The Michael J. Fox Foundation: Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease through an aggressively funded research agenda. The Foundation has funded $149 million in research to date. For more information please visit www.michaeljfox.org.

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 38 countries and has 7,800 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning website at http://www.sigma-aldrich.com.

Cautionary Statement: This release contains forward-looking statements relating to future strategic actions and initiatives and similar intentions and beliefs and other statements regarding the Companies' expecta
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
2. GenVec Receives National Cancer Institute Grant to Expand Cancer Program
3. Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
4. Oxygen Biotherapeutics, Inc. Receives Phase II Trial Approval in Israel
5. Childrens Hospital Receives Six-Year Federal Contract to Study Antibiotic Use in Children With Urinary Tract Infections
6. ISTA Pharmaceuticals Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
7. Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
8. Cytopias CYT387 Receives FDA Clearance to Start US Clinical Trials
9. Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
10. Families of Spinal Muscular Atrophy Receives FDA Orphan Drug Designation For Quinazoline495 For The Treatment of Spinal Muscular Atrophy
11. Mennen Medical Receives Frost & Sullivan 2009 European Patient Monitoring Technology Leadership Award

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009).../PRNewswire/-- ChemoCentryx,Inc.,announcedtodayth...(theProspectiveRandomizedOralTherapyEvaluationinCr...ientswithmoderate-to-severeCrohn,sdiseasedemonstra...lityprofile.Thestudydemonstratedevidenceofclinical...a70-pointdecreaseintheCrohn,sDiseaseActivityIndex(...
(Date:11/24/2009)...wswire-FirstCall/--Vermillion,Inc.(VRML)(PinkSheet...ationandDisclosureStatementtoday,November24,2009,w...elaware.AhearingtoconsiderapprovaloftheDisclosureS...thehearingontheconfirmationofthePlanscheduledforJa...llclaimsinfull.ThePlanisexpected,ifapproved,toallo...
(Date:11/24/2009).../--Accumetrics,Inc.,aprivately-helddeveloperandmar...sy-to-usediagnosticsystemformeasuringanindividual,...174;andaspirin),announcedtodaythatTimothyI.Still,P...hiefFinancialOfficerofAccumetrics,willbepresenting...hCareConferencebeingheldinNewYorkCityonDecember1-2...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Seizures Not Epilepsy Itself May Raise Birth Risks 54172 1Seizures Not Epilepsy Itself May Raise Birth Risks 54172 2Oral Drug Ups Survival in Advanced Prostate Cancer Cases 54170 1Oral Drug Ups Survival in Advanced Prostate Cancer Cases 54170 2For Macho Men Doctor Visits Are Less Likely 54168 1For Macho Men Doctor Visits Are Less Likely 54168 2
...A -- (MARKET WIRE) -- June 14,2007 -- Targeted Ge...ng data from the dose escalation arm of the ongoin... with inflammatory,arthritis. Philip J. Mease, M.D...ton School of Medicine, chief of rheumatology,clin...icing,physician with Seattle Rheumatology Associat...
...PRNewswire/ -- Prolexys,Pharmaceuticals and announ...of the selective small molecule anti-tumor agent,...,s,chemi-proteomics technology to understand the m...published in the June 14, 2007 issue,of the journa...l,voltage- dependent anion channels (VDACs) -- a n...
Other Medicine Technology:Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 2Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 3Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 4Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 5Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 6Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 2Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 3
(Date:11/25/2009)...,ImproveCare ,, WASHINGTON,Nov.25/PRNewswire-...KaiserPermanentetodayannouncedanexcitingprogramdes...AandKaiserPermanentearelaunchingapilotprogramtoexc...eNationwideHealthInformationNetwork(NHIN)createdby...bilitytosharecriticalhealthinformationisessentialt...
(Date:11/25/2009)...pportofFeedingAmerica,sSNAPOutreachEfforts ,, ...ica,thenation,slargesthunger-relieforganization,to...CharitableFoundationtosupportFeedingAmerica,seffor...utritionAssistanceProgram(SNAP),formerlynamedtheFo...icafoodbanksimproveaccessandprovidepre-screeningan...
(Date:11/25/2009)...l to normal human development - the Wnt/Wingless (...athways - interact in ways that can promote tumor ... University of Texas M. D. Anderson Cancer Center ..., This newly characterized interaction involves t...invasive cancer - activation of EGFR, elevated pro...
(Date:11/25/2009)...an, MD, FACP, a former Board Chair and one of the ... Angeles Biomedical Research Institute at Harbor-U... the American College of Physicians for his lifeti...ril 22, 2010 meeting in Toronto, the American Coll... Ralph O. Claypoole Sr. Memorial Award for Devotio...
(Date:11/25/2009)...thwestern Medical Center soon will begin implantin...tients with upper spinal-cord injuries or other di.... , UT Southwestern University Hospital St. Pa...of 25 in the country currently equipped to implant...tem. , The device is designed to give patients m...
Breaking Medicine News(10 mins):Health News:VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 3Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:1 of LA BioMed's founders to be honored 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2
...ne, Fox Chase Cancer Center and Geisinger Health S...t will speed the translation of medical and health...patient care. , As part of the agreement, the th...oral, and social causes of such diseases as diabet...
...sts and Investors Will Gather Feb. 17 in New York...oducts, PHILADELPHIA, Aug. 12 RRY Publications t...s for the 4th Annual Stem Cell Summit,the premier ...n intensive one-day event that allows attendees to...
...ids Get Fatter with Age, Study Finds , Have you ev...re? This study examined why lower eyelids get bulg...ree different age groups (12 29 years old, 30 54...e; lower eyelids actually get fatter. This signif...
... Aims To Raise Record Funds For the Pediatric Can...eles, LOS ANGELES, Aug. 12 Los Angeles will agai..., celebrities and philanthropists,when the 22nd An...bu Triathlon will put their skills to,the test on ...
...euticals,Inc. (NYSE: BRL ) announced today that i...ement Agreement and a License Agreement with Boehr...nvolving Boehringer Ingelheim,s,Mirapex(R) product...heim,s Aggrenox(R) product and Duramed Pharmaceuti...
...atients, emotional distress to improve quality of ...) -- Cancer patients are at increased risk for sui...st study, researchers at the University of Washing... 100,000 person-years in the general population. ,...
Other Medicine News:Health News:Temple, Fox Chase and Geisinger create Keystone Institute for Translational Medicine 2Health News:Preliminary Lineup Set for 4th Annual Stem Cell Summit 2Health News:News briefs from the American Society of Plastic Surgery 2Health News:Nautica Malibu Triathlon, Presented By Toyota, Showcases Athleticism, Philanthropy in 22nd Year 2Health News:Nautica Malibu Triathlon, Presented By Toyota, Showcases Athleticism, Philanthropy in 22nd Year 3Health News:Nautica Malibu Triathlon, Presented By Toyota, Showcases Athleticism, Philanthropy in 22nd Year 4Health News:Nautica Malibu Triathlon, Presented By Toyota, Showcases Athleticism, Philanthropy in 22nd Year 5Health News:Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges 2Health News:Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges 3Health News:Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges 4Health News:Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges 5Health News:Older Patients With Cancer at Heightened Suicide Risk 2
...tact lenses used for corneal refractive therapy, a... (myopia). The patient wears the lenses overnight ...ing the day, nearsightedness is corrected or great... lenses apply slight pressure to the center of the...
...e major challenges to operating your own Nuclear C...cedure includes:, NRC, state and other licensure...echnologist., New, dual head nuclear imaging camer...ure supplies, including pharmaceuticals., Radiatio...
... 330 ,Straight, ,Konan realized an ideal coa...een lenses for observation. This illumination shou...aryngology, ,Konan offers what no other conven...nction (1:3) and a clear image at every possible m...
...xperienced provider of mobile catheterization serv...bile laboratories serving hospital networks are mo...o another in a particular hospital network or geog...ped and operated by MedCath medical technicians an...
Medicine Products: